Combination therapies are gaining traction in oncology for their ability to synergistically enhance treatment efficacy. Case studies often explore novel combinations, such as chemo-immunotherapy or radiation combined with targeted agents, to maximize anti-cancer effects. For instance, combining immune checkpoint inhibitors with radiation has shown promise in overcoming resistance and improving survival in metastatic cancers. These cases underscore the importance of tailoring combinations to individual patient profiles, leveraging the strengths of each modality while minimizing toxicity. By highlighting real-world successes, these studies encourage further research and clinical trials to establish the most effective multi-modal approaches to cancer treatment.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States